Sign Up | Log In | What is SocialPicks?

9 pts

Opinion on Dendreon Corp (DNDN) Sector: Healthcare > Industry: Biotechnology & Drugs
BioMed Stock Movers: DNDN, EXAS, KG

Apr 08, 2009 03:35 PM GMT

Mike Havrilla

Return	Risk
+1.04%	LOW

Principal

Profile & Performance

Subscribe to author

Dendreon (DNDN) has stalled out around $6.50 per share after a major rally on news of upcoming presentation at a medical conference later this month. DNDN expects to report Provenge clinical trial results some time before the end of April, although it did not guarantee this would occur at the upcoming presentation.

The recent spike in shares of DNDN and upcoming presentation do not provide any clarity on whether Provenge results will be sufficient for attaining FDA approval and the pending data release will determine the Company's fate.

http://biomedreports.com/articles/most-popular/767-fda-calend...

King Pharma (KG) on Goldman's conviction buy list with $10 price target

Check out my article at

http://biomedreports.com/articles/most-popular/683-king-pharm...

EXACT Sciences (EXAS) moving up steadily since briefly moving below a dollar late last week. EXAS trading on light volumes this week, but moving to the upside with last trade at $1.19 today. Below is a link to my two latest articles on EXAS:

http://biomedreports.com/articles/latest-news/678-exact-scien...

Disclosure: I own shares of EXAS.

DNDN: This call was made on 04/08/09 @ $6.57

Rating:	$6.57 (04/08/09)
Closed:	04/14/2009 @ $21.4 (-225.72% in 6 days)

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.37%	379
2	Gerald Greene	18.14	+70.70%	209
3	stockmarketfunding.com	17.66	+25.67%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+78.05%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
V	Visa Inc
IBM	International Business Machines Corp
MO	Altria Group Inc
RIMM	Research in Motion Ltd
AAPL	Apple Computer Inc
EBAY	eBay Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

PARD		PARD - Azimuth Opportunity Bets on Poniard's Survival. Should you ? by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla
NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla

... more »

Dendreon Corp (DNDN)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

76.0%

Top:

75.0%

Get Daily Email Alerts

Subscribe to Mike Havrilla

Receive Free Ideas Daily for This Sector

Latest Picks by Mike Havrilla

Symbol	SP Sentiment	Return	Since
PBIO	N/A	+0.00%	11/24/09
PUMD	N/A	n/a	11/23/09
SCLN	N/A	-3.86%	11/23/09
TSPT	N/A	+0.00%	11/23/09
ABIO		+0.00%	11/23/09

View All >

Mike Havrilla previously rated DNDN

-2.65%	BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen 11/20/2009	9
+5.55%	New Global Equity Index to Track Immunotherapy, Vaccine Stocks 11/04/2009	9
-0.86%	New Stock Indexes to Track Trends in Healthcare Sector 10/28/2009	9
-3.58%	Quantum Immunologics: Developing Universal Therapeutic Cancer Vaccine 10/25/2009	9
+4.25%	ImmunoCellular (OTC: IMUC.OB): Top Gainer in Cancer Immunotherapy Index 09/16/2009	9
-0.38%	Quantum Immunologics: Rodman Conference Recap 09/15/2009	9
+12.11%	Mentor Capital (MNTR.pk): A Risk-Mitigated Call Option on QI’s Cancer Immunotherapy 08/29/2009	9
+0.30%	Mentor Capital (MNTR.PK) Top Gainer in Cancer Immunotherapy Index 08/28/2009	9
-1.70%	Mentor Capital (MNTR.PK): A Stealth Cancer Immunotherapy Play 08/26/2009	9
-1.59%	New Indexes to Track Healthcare Trends and More 08/04/2009	9
+14.05%	Access Pharma: A Cancer Biotech Call Option Trade 05/27/2009	9
-20.61%	Bullish on DNDN ... 04/14/2009	0
+0.00%	Updated FDA, Clinical Trial Calendars: CTIC, DNDN, MRX, JNJ, MEDX 04/14/2009	9
+3.10%	Bearish on DNDN ... 04/07/2009	-1
-0.73%	FDA Calendar Updates: SNTS, CEPH, AZN, DNDN, GILD, NVO 04/06/2009	9
+89.63%	Calendar of 163 FDA Decisions and Clinical Trials 01/21/2009	9
-3.25%	UpDown Virtual Investing: Earn Real Money with Zero Risk 12/28/2008	9
+2.90%	A New Global Healthcare Composite Index 11/23/2008	9
+0.00%	A New Index of Emerging Biotech & Pharma Companies 11/22/2008	9

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Dendreon Corp (DNDN) Sector: Healthcare > Industry: Biotechnology & Drugs BioMed Stock Movers: DNDN, EXAS, KG

Opinion on Dendreon Corp (DNDN) Sector: Healthcare > Industry: Biotechnology & Drugs
BioMed Stock Movers: DNDN, EXAS, KG